China Medical System Holdings Limited (0867.HK)
HKD 7.36
(-0.67%)
HKD 7.36
(-0.67%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 2.4 Billion CNY | -26.33% |
| 2022 | 3.25 Billion CNY | 8.01% |
| 2021 | 3.01 Billion CNY | 19.25% |
| 2020 | 2.53 Billion CNY | 29.06% |
| 2019 | 1.96 Billion CNY | 5.99% |
| 2018 | 1.84 Billion CNY | 10.45% |
| 2017 | 1.67 Billion CNY | 21.72% |
| 2016 | 1.37 Billion CNY | 38.16% |
| 2015 | 995.93 Million CNY | -4.76% |
| 2014 | 1.04 Billion CNY | 67.81% |
| 2013 | 623.14 Million CNY | 17.4% |
| 2012 | 530.79 Million CNY | 35.61% |
| 2011 | 391.4 Million CNY | 92.93% |
| 2010 | 202.87 Million CNY | 43.65% |
| 2009 | 141.23 Million CNY | 38.47% |
| 2008 | 101.99 Million CNY | 60.76% |
| 2007 | 63.44 Million CNY | 102.7% |
| 2006 | 31.29 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 455.21 Million CNY | 89.72% |
| 2024 Q2 | 455.21 Million CNY | 0.0% |
| 2023 Q1 | 960.52 Million CNY | 31.56% |
| 2023 FY | 2.4 Billion CNY | -26.33% |
| 2023 Q4 | 239.94 Million CNY | 0.0% |
| 2023 Q3 | 239.94 Million CNY | -75.02% |
| 2023 Q2 | 960.52 Million CNY | 0.0% |
| 2022 Q1 | 899.36 Million CNY | 29.41% |
| 2022 FY | 3.25 Billion CNY | 8.01% |
| 2022 Q4 | 730.12 Million CNY | 0.0% |
| 2022 Q3 | 730.12 Million CNY | -18.82% |
| 2022 Q2 | 899.36 Million CNY | 0.0% |
| 2021 Q3 | 694.96 Million CNY | -14.6% |
| 2021 FY | 3.01 Billion CNY | 19.25% |
| 2021 Q1 | 813.74 Million CNY | 30.1% |
| 2021 Q4 | 694.96 Million CNY | 0.0% |
| 2021 Q2 | 813.74 Million CNY | 0.0% |
| 2020 Q3 | 625.48 Million CNY | -2.22% |
| 2020 FY | 2.53 Billion CNY | 29.06% |
| 2020 Q1 | 639.71 Million CNY | 61.78% |
| 2020 Q2 | 639.71 Million CNY | 0.0% |
| 2020 Q4 | 625.48 Million CNY | 0.0% |
| 2019 Q1 | 584.94 Million CNY | 31.1% |
| 2019 Q3 | 395.4 Million CNY | -32.4% |
| 2019 Q4 | 395.4 Million CNY | 0.0% |
| 2019 FY | 1.96 Billion CNY | 5.99% |
| 2019 Q2 | 584.94 Million CNY | 0.0% |
| 2018 Q2 | 478.77 Million CNY | 0.0% |
| 2018 Q4 | 446.16 Million CNY | 0.0% |
| 2018 FY | 1.84 Billion CNY | 10.45% |
| 2018 Q1 | 478.77 Million CNY | 10.08% |
| 2018 Q3 | 446.16 Million CNY | -6.81% |
| 2017 Q1 | 402.47 Million CNY | 11.47% |
| 2017 FY | 1.67 Billion CNY | 21.72% |
| 2017 Q4 | 434.92 Million CNY | 0.0% |
| 2017 Q3 | 434.92 Million CNY | 8.06% |
| 2017 Q2 | 402.47 Million CNY | 0.0% |
| 2016 FY | 1.37 Billion CNY | 38.16% |
| 2016 Q1 | 326.89 Million CNY | 30.53% |
| 2016 Q2 | 326.89 Million CNY | 0.0% |
| 2016 Q3 | 361.07 Million CNY | 10.45% |
| 2016 Q4 | 361.07 Million CNY | 0.0% |
| 2015 Q4 | 250.44 Million CNY | 0.0% |
| 2015 FY | 995.93 Million CNY | -4.76% |
| 2015 Q2 | 247.52 Million CNY | 0.0% |
| 2015 Q1 | 247.52 Million CNY | -21.8% |
| 2015 Q3 | 250.44 Million CNY | 1.18% |
| 2014 Q2 | 206.33 Million CNY | 0.0% |
| 2014 Q1 | 206.33 Million CNY | 28.33% |
| 2014 FY | 1.04 Billion CNY | 67.81% |
| 2014 Q4 | 316.51 Million CNY | 0.0% |
| 2014 Q3 | 316.51 Million CNY | 53.4% |
| 2013 Q3 | 160.77 Million CNY | 2.19% |
| 2013 Q4 | 160.77 Million CNY | 0.0% |
| 2013 FY | 623.14 Million CNY | 17.4% |
| 2013 Q1 | 157.32 Million CNY | 15.32% |
| 2013 Q2 | 157.32 Million CNY | 0.0% |
| 2012 FY | 530.79 Million CNY | 35.61% |
| 2012 Q2 | - CNY | -100.0% |
| 2012 Q1 | 160.19 Million CNY | 0.0% |
| 2012 Q3 | 137.6 Million CNY | 0.0% |
| 2012 Q4 | 136.42 Million CNY | -0.86% |
| 2011 Q2 | - CNY | 0.0% |
| 2011 FY | 391.4 Million CNY | 92.93% |
| 2011 Q4 | - CNY | 0.0% |
| 2010 FY | 202.87 Million CNY | 43.65% |
| 2010 Q4 | - CNY | 0.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2009 FY | 141.23 Million CNY | 38.47% |
| 2008 FY | 101.99 Million CNY | 60.76% |
| 2007 FY | 63.44 Million CNY | 102.7% |
| 2006 FY | 31.29 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 105.03 Million HKD | -2185.761% |
| Grand Pharmaceutical Group Limited | 1.87 Billion HKD | -27.71% |
| Extrawell Pharmaceutical Holdings Limited | -162.94 Million HKD | 1573.43% |
| Wai Yuen Tong Medicine Holdings Limited | -15.35 Million HKD | 15735.191% |
| Qianhai Health Holdings Limited | -52.7 Million HKD | 4655.431% |
| Lee's Pharmaceutical Holdings Limited | 16.69 Million HKD | -14278.608% |
| Essex Bio-Technology Limited | 275.25 Million HKD | -772.246% |
| Tongfang Kontafarma Holdings Limited | -28.84 Million HKD | 8424.169% |
| PuraPharm Corporation Limited | -106.08 Million HKD | 2363.308% |
| SSY Group Limited | 1.31 Billion HKD | -82.08% |
| JBM (Healthcare) Limited | 130.46 Million HKD | -1740.323% |
| Jacobson Pharma Corporation Limited | 266.96 Million HKD | -799.336% |
| China Resources Pharmaceutical Group Limited | 3.85 Billion HKD | 37.707% |